This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Source: OpenUrlAbstract/FREE Full Text
Investigators from multiple institutions conducted a retrospective cohort study to assess whether acid suppression therapy (AST) in the first year of life is associated with childhood fracture. Children were eligible if they were born between 2001 and 2013 and received continuous care in the Military Healthcare System for at least the first 2 years and up to 14 years of life. Demographic variables and covariates linked to fracture risk (preterm birth, low birth weight, obesity, antiepileptic medication use, and fracture before age 1 year) were obtained from military records.
The primary predictor was ≥1 outpatient prescription for AST in the first year of life as determined from civilian and military outpatient pharmacy records. AST therapy included a proton pump inhibitor (PPI), a histamine H2-receptor antagonist (H2RA), or …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.